Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt
- PMID: 26107252
- PMCID: PMC4529369
- DOI: 10.1038/nm.3908
Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt
Abstract
The inflammasome activates caspase-1 and the release of interleukin-1β (IL-1β) and IL-18, and several inflammasomes protect against intestinal inflammation and colitis-associated colon cancer (CAC) in animal models. The absent in melanoma 2 (AIM2) inflammasome is activated by double-stranded DNA, and AIM2 expression is reduced in several types of cancer, but the mechanism by which AIM2 restricts tumor growth remains unclear. We found that Aim2-deficient mice had greater tumor load than Asc-deficient mice in the azoxymethane/dextran sodium sulfate (AOM/DSS) model of colorectal cancer. Tumor burden was also higher in Aim2(-/-)/Apc(Min/+) than in APC(Min/+) mice. The effects of AIM2 on CAC were independent of inflammasome activation and IL-1β and were primarily mediated by a non-bone marrow source of AIM2. In resting cells, AIM2 physically interacted with and limited activation of DNA-dependent protein kinase (DNA-PK), a PI3K-related family member that promotes Akt phosphorylation, whereas loss of AIM2 promoted DNA-PK-mediated Akt activation. AIM2 reduced Akt activation and tumor burden in colorectal cancer models, while an Akt inhibitor reduced tumor load in Aim2(-/-) mice. These findings suggest that Akt inhibitors could be used to treat AIM2-deficient human cancers.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4529369/bin/nihms703777f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4529369/bin/nihms703777f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4529369/bin/nihms703777f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4529369/bin/nihms703777f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4529369/bin/nihms703777f5.gif)
Similar articles
-
Immunobiology and structural biology of AIM2 inflammasome.Mol Aspects Med. 2020 Dec;76:100869. doi: 10.1016/j.mam.2020.100869. Epub 2020 Jul 10. Mol Aspects Med. 2020. PMID: 32660715 Free PMC article. Review.
-
AIM2 Inflammasome Assembly and Signaling.Adv Exp Med Biol. 2019;1172:143-155. doi: 10.1007/978-981-13-9367-9_7. Adv Exp Med Biol. 2019. PMID: 31628655 Review.
-
Macrophage Uptake of Necrotic Cell DNA Activates the AIM2 Inflammasome to Regulate a Proinflammatory Phenotype in CKD.J Am Soc Nephrol. 2018 Apr;29(4):1165-1181. doi: 10.1681/ASN.2017080863. Epub 2018 Feb 9. J Am Soc Nephrol. 2018. PMID: 29439156 Free PMC article.
-
The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway.Cell Mol Immunol. 2017 Jan;14(1):127-142. doi: 10.1038/cmi.2016.35. Epub 2016 Aug 15. Cell Mol Immunol. 2017. PMID: 27524110 Free PMC article.
-
The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense.Cell Rep. 2015 Dec 1;13(9):1922-36. doi: 10.1016/j.celrep.2015.10.040. Epub 2015 Nov 19. Cell Rep. 2015. PMID: 26655906 Free PMC article.
Cited by
-
The role of kinases in peripheral nerve regeneration: mechanisms and implications.Front Neurol. 2024 Apr 16;15:1340845. doi: 10.3389/fneur.2024.1340845. eCollection 2024. Front Neurol. 2024. PMID: 38689881 Free PMC article. Review.
-
Cytosolic DNA sensor AIM2 promotes KRAS-driven lung cancer independent of inflammasomes.Cancer Sci. 2024 Jun;115(6):1834-1850. doi: 10.1111/cas.16171. Epub 2024 Apr 9. Cancer Sci. 2024. PMID: 38594840 Free PMC article.
-
Cytosolic DNA sensors in neurodegenerative diseases: from physiological defenders to pathological culprits.EMBO Mol Med. 2024 Apr;16(4):678-699. doi: 10.1038/s44321-024-00046-w. Epub 2024 Mar 11. EMBO Mol Med. 2024. PMID: 38467840 Free PMC article. Review.
-
AIM2 regulates autophagy to mitigate oxidative stress in aged mice with acute liver injury.Cell Death Discov. 2024 Mar 1;10(1):107. doi: 10.1038/s41420-024-01870-2. Cell Death Discov. 2024. PMID: 38429284 Free PMC article.
-
Oral streptococci S. anginosus and S. mitis induce distinct morphological, inflammatory, and metabolic signatures in macrophages.Infect Immun. 2024 Mar 12;92(3):e0053623. doi: 10.1128/iai.00536-23. Epub 2024 Jan 30. Infect Immun. 2024. PMID: 38289109 Free PMC article.
References
-
- Weir HK, et al. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J. Natl. Cancer Inst. 2003;95:1276–1299. - PubMed
-
- Hugot JP, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599–603. - PubMed
-
- Ogura Y, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603–606. - PubMed
-
- Dupaul-Chicoine J, et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity. 2010;32:367–378. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA156330/CA/NCI NIH HHS/United States
- P01 DK094779/DK/NIDDK NIH HHS/United States
- T32 CA009156/CA/NCI NIH HHS/United States
- P30 DK034987/DK/NIDDK NIH HHS/United States
- P30 CA016086/CA/NCI NIH HHS/United States
- R01 EY024556/EY/NEI NIH HHS/United States
- R01 CA084442/CA/NCI NIH HHS/United States
- R01 AI029564/AI/NIAID NIH HHS/United States
- U19 AI067798/AI/NIAID NIH HHS/United States
- R15 DK098754/DK/NIDDK NIH HHS/United States
- R37 AI029564/AI/NIAID NIH HHS/United States
- NIDDK F32-K088417-01/PHS HHS/United States
- F32 DK088417/DK/NIDDK NIH HHS/United States
- R37-AI029564/AI/NIAID NIH HHS/United States
- F32 DK098916/DK/NIDDK NIH HHS/United States
- U19-AI067798/AI/NIAID NIH HHS/United States
- R01-CA156330/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous